| Sean C Kerby, MD | |
|
12261 Highway 49, Suite 11, Gulfport, MS 39503-2975 | |
| (228) 867-5185 | |
| (228) 867-5189 |
| Full Name | Sean C Kerby |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 27 Years |
| Location | 12261 Highway 49, Gulfport, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730268939 | NPI | - | NPPES |
| 07885561 | Medicaid | MS | |
| DE2565 | Other | TN | RR MEDICARE GROUP |
| 3861661 | Medicaid | TN | |
| P00344233 | Other | TN | RR MEDICARE |
| 4114136 | Other | TN | BCBST |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 34974 (Tennessee) | Secondary |
| 207Q00000X | Family Medicine | 20062 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Deaconess Homecare- Region 1 | Laurel, MS | Home health agency |
| Deaconess Hospice | Biloxi, MS | Hospice |
| Memorial Hospital At Gulfport | Gulfport, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Hospital At Gulfport | 2466524012 | 376 |
| Exceed Physical Therapy Llc | 8123378338 | 82 |
News Archive
Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.
A team led by scientists at The Scripps Research Institute has been awarded $2.1 million by the Department of Defense Congressionally Directed Medical Research Programs to study several compounds with the potential to greatly improve the quality of life for those with amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease.
A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes shows that children with a strong family history of cardiovascular disease (CVD) and/or type 2 diabetes were found to have cholesterol levels significantly higher than children with no family history of those conditions.
Three paralyzed men were able to take their first steps after their accidents due to the spinal implants from doctors in Switzerland.
Researchers at Karolinska Institutet in Sweden have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself - but just as important is how this study, which is published in the highly respected journal Nature Methods, was conducted.
› Verified 2 days ago
| Entity Name | Memorial Hospital At Gulfport |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215546635 PECOS PAC ID: 2466524012 Enrollment ID: O20090515000396 |
News Archive
Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.
A team led by scientists at The Scripps Research Institute has been awarded $2.1 million by the Department of Defense Congressionally Directed Medical Research Programs to study several compounds with the potential to greatly improve the quality of life for those with amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease.
A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes shows that children with a strong family history of cardiovascular disease (CVD) and/or type 2 diabetes were found to have cholesterol levels significantly higher than children with no family history of those conditions.
Three paralyzed men were able to take their first steps after their accidents due to the spinal implants from doctors in Switzerland.
Researchers at Karolinska Institutet in Sweden have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself - but just as important is how this study, which is published in the highly respected journal Nature Methods, was conducted.
› Verified 2 days ago
| Entity Name | Lhcg Cxcv, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659946796 PECOS PAC ID: 7113322009 Enrollment ID: O20210816001115 |
News Archive
Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.
A team led by scientists at The Scripps Research Institute has been awarded $2.1 million by the Department of Defense Congressionally Directed Medical Research Programs to study several compounds with the potential to greatly improve the quality of life for those with amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease.
A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes shows that children with a strong family history of cardiovascular disease (CVD) and/or type 2 diabetes were found to have cholesterol levels significantly higher than children with no family history of those conditions.
Three paralyzed men were able to take their first steps after their accidents due to the spinal implants from doctors in Switzerland.
Researchers at Karolinska Institutet in Sweden have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself - but just as important is how this study, which is published in the highly respected journal Nature Methods, was conducted.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sean C Kerby, MD Po Box 1810, Gulfport, MS 39502-1810 Ph: (228) 865-1453 | Sean C Kerby, MD 12261 Highway 49, Suite 11, Gulfport, MS 39503-2975 Ph: (228) 867-5185 |
News Archive
Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.
A team led by scientists at The Scripps Research Institute has been awarded $2.1 million by the Department of Defense Congressionally Directed Medical Research Programs to study several compounds with the potential to greatly improve the quality of life for those with amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease.
A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes shows that children with a strong family history of cardiovascular disease (CVD) and/or type 2 diabetes were found to have cholesterol levels significantly higher than children with no family history of those conditions.
Three paralyzed men were able to take their first steps after their accidents due to the spinal implants from doctors in Switzerland.
Researchers at Karolinska Institutet in Sweden have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself - but just as important is how this study, which is published in the highly respected journal Nature Methods, was conducted.
› Verified 2 days ago
Marcus John Wilson, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1110 Broad Ave, Suite 700, Gulfport, MS 39501 Phone: 228-864-0314 Fax: 228-868-8345 | |
Daniel Salmeron, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14116 Customs Blvd, Gulfport, MS 39503 Phone: 601-957-6300 | |
Dr. Paulette L. Foster-galbraith, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 130 Darran St, Gulfport, MS 39503 Phone: 228-831-1988 Fax: 228-832-3844 | |
Dr. Donald D. Weaver, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1612 31st Ave, Gulfport, MS 39501 Phone: 228-864-8454 Fax: 228-865-1457 | |
Taylor Hairston, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 15190 Community Rd, Gulfport, MS 39503 Phone: 228-220-5200 | |
Candace Worsham, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1924 30th Ave, Gulfport, MS 39501 Phone: 228-863-7117 | |
Mitchell Adam Sanford, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12057 Highway 49 Ste C, Gulfport, MS 39503 Phone: 228-832-9385 Fax: 888-498-3529 |